STOCK TITAN

Invesco Mort Financials

IVR
Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Invesco Mort (IVR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Neutral
4/9

Invesco Mort passes 4 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Cash-Backed
1.55x

For every $1 of reported earnings, Invesco Mort generates $1.55 in operating cash flow ($157.1M OCF vs $101.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$295.3M
YoY+3.1%
5Y CAGR+1.1%

Invesco Mort generated $295.3M in revenue in fiscal year 2025. This represents an increase of 3.1% from the prior year.

EBITDA
N/A
Net Income
$101.3M
YoY+69.1%
10Y CAGR-1.1%

Invesco Mort reported $101.3M in net income in fiscal year 2025. This represents an increase of 69.1% from the prior year.

EPS (Diluted)
$1.32
YoY+103.1%

Invesco Mort earned $1.32 per diluted share (EPS) in fiscal year 2025. This represents an increase of 103.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$56.0M
YoY-23.7%
5Y CAGR-17.7%
10Y CAGR+0.5%

Invesco Mort held $56.0M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
72M
YoY+16.3%

Invesco Mort had 72M shares outstanding in fiscal year 2025. This represents an increase of 16.3% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
34.3%
YoY+13.4pp
5Y CAGR+631.9pp

Invesco Mort's net profit margin was 34.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 13.4 percentage points from the prior year.

Return on Equity
12.7%
YoY+4.5pp
5Y CAGR+135.2pp
10Y CAGR+7.7pp

Invesco Mort's ROE was 12.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 4.5 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

IVR Income Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Revenue $77.9M+6.8% $72.9M+3.2% $70.6M-4.4% $73.8M-3.0% $76.1M+3.1% $73.8M+8.5% $68.0M-0.8% $68.6M
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $1.8M-2.4% $1.8M-11.7% $2.0M+22.7% $1.7M+3.4% $1.6M-10.9% $1.8M-7.1% $1.9M+8.2% $1.8M
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense $56.6M+2.4% $55.3M+4.6% $52.9M-3.9% $55.0M-11.9% $62.4M-5.9% $66.3M+11.7% $59.4M-3.6% $61.6M
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income $51.5M-3.7% $53.5M+329.2% -$23.3M-218.8% $19.6M+460.2% $3.5M-91.4% $40.7M+402.4% -$13.5M-146.2% $29.1M
EPS (Diluted) N/A $0.74+285.0% $-0.40-253.8% $0.26 N/A $0.63+265.8% $-0.38-177.6% $0.49

IVR Balance Sheet

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Total Assets $6.5B+8.6% $6.0B+10.4% $5.4B-12.3% $6.2B+8.3% $5.7B-6.5% $6.1B+20.0% $5.1B-3.2% $5.2B
Current Assets N/A N/A N/A N/A N/A N/A N/A N/A
Cash & Equivalents $56.0M-4.3% $58.5M-1.4% $59.4M+38.5% $42.9M-41.6% $73.4M+52.1% $48.3M-17.9% $58.8M-1.9% $59.9M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $5.7B+9.4% $5.2B+10.7% $4.7B-13.1% $5.4B+8.9% $5.0B-5.1% $5.2B+21.3% $4.3B-3.1% $4.4B
Current Liabilities N/A N/A N/A N/A N/A N/A N/A N/A
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity $797.5M+3.6% $769.6M+8.5% $709.4M-6.6% $759.2M+3.9% $730.7M-14.7% $857.0M+12.9% $759.2M-3.4% $785.6M
Retained Earnings -$3.6B+0.6% -$3.6B+0.7% -$3.6B-1.4% -$3.6B-0.2% -$3.6B-0.9% -$3.5B+0.3% -$3.6B-1.1% -$3.5B

IVR Cash Flow Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Operating Cash Flow $59.8M+60.4% $37.3M-8.2% $40.6M+110.0% $19.3M-68.7% $61.9M+100.6% $30.8M-6.5% $33.0M-42.6% $57.5M
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow -$520.4M+7.7% -$564.0M-179.7% $708.0M+237.1% -$516.5M-228.7% $401.4M+138.9% -$1.0B-1175.5% $95.9M+158.5% $37.1M
Financing Cash Flow $446.3M-13.7% $516.9M+169.9% -$739.6M-258.1% $467.8M+211.2% -$420.8M-142.7% $986.0M+775.5% -$146.0M-57.4% -$92.7M
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

IVR Financial Ratios

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin 66.1%-7.2pp 73.3%+106.4pp -33.0%-59.6pp 26.6%+22.0pp 4.6%-50.5pp 55.2%+74.9pp -19.8%-62.2pp 42.5%
Return on Equity 6.5%-0.5pp 7.0%+10.2pp -3.3%-5.9pp 2.6%+2.1pp 0.5%-4.3pp 4.8%+6.5pp -1.8%-5.5pp 3.7%
Return on Assets 0.8%-0.1pp 0.9%+1.3pp -0.4%-0.8pp 0.3%+0.3pp 0.1%-0.6pp 0.7%+0.9pp -0.3%-0.8pp 0.6%
Current Ratio N/A N/A N/A N/A N/A N/A N/A N/A
Debt-to-Equity 7.12+0.4 6.75+0.1 6.61-0.5 7.11+0.3 6.78+0.7 6.10+0.4 5.67+0.0 5.66
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Similar Companies

Frequently Asked Questions

Invesco Mort (IVR) reported $295.3M in total revenue for fiscal year 2025. This represents a 3.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Invesco Mort (IVR) revenue grew by 3.1% year-over-year, from $286.5M to $295.3M in fiscal year 2025.

Yes, Invesco Mort (IVR) reported a net income of $101.3M in fiscal year 2025, with a net profit margin of 34.3%.

Invesco Mort (IVR) reported diluted earnings per share of $1.32 for fiscal year 2025. This represents a 103.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Invesco Mort (IVR) had a net profit margin of 34.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Invesco Mort (IVR) has a return on equity of 12.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Invesco Mort (IVR) generated $157.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Invesco Mort (IVR) had $6.5B in total assets as of fiscal year 2025, including both current and long-term assets.

Invesco Mort (IVR) had 72M shares outstanding as of fiscal year 2025.

Invesco Mort (IVR) had a debt-to-equity ratio of 7.12 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Invesco Mort (IVR) had a return on assets of 1.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Invesco Mort (IVR) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Invesco Mort (IVR) has an earnings quality ratio of 1.55x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top